Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kanglong capsule in advanced primary hepatocellular carcinoma
CTR20140612Phase 2Active
- Sponsor
- Changsha Dongya Tumor Prevention and Treatment Research Institute
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Kanglong Capsule in hepatocellular carcinoma (HCC), sponsored by Changsha Dongya Tumor Prevention and Treatment Research Institute. Started Sep 2014; status: active.
02
Drugs
Kanglong Capsule
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on CTR20140612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140612.